期刊文献+

组织因子与脓毒症的关系 被引量:5

Tissue factor and sepsis
在线阅读 下载PDF
导出
摘要 脓毒症是感染继发的全身炎性反应综合征,重组活化蛋白C的抗凝作用对脓毒症患者已取得肯定疗效,使脓毒症导致的凝血异常受到重视。组织因子是感染诱发的主要凝血因子。该文作者就其与脓毒症的关系作一综述。 Sepsis represents an uncontrolled systemic inflammatory response secondary to infections. Recombinant human activated protein C can significantly reduce the mortality of the patients with severe sepsis and has called much attention to the dysfunction of the coagulation system. Tissue factor is the primary coagulating factor induced by infection. This review summarizes the correlation between pathogenesis of sepsis and tissue factor.
出处 《医学研究生学报》 CAS 2008年第4期435-437,共3页 Journal of Medical Postgraduates
关键词 组织因子 脓毒症 Tissue factor Sepsis
作者简介 赵峰(1979-),男,江苏徐州人,医师,医学硕士,从事麻醉科专业。现在江苏省中医院麻醉科工作。 通讯作者:徐建国(1944-),男,辽宁沈阳人,主任医师,博士研究生导师,从事麻醉学专业。
  • 相关文献

参考文献19

  • 1Levy MM, Fink MP, Marshall JC,et al. 2001 SCCM/ES1CM/ ACCP/ATS/SIS International Sepsis Definitions Conference[ J]. Intensive Care Med ,2003,29(4 ) :530-538.
  • 2Schrier RW, Wang W. Acute Renal Failure and Sepsis [ J ]. N Engl J Med,2004,351 (2) : 159-169.
  • 3Hotchkiss RS, Karl 1E. The Pathophysiology and Treatment of Sepsis[ J]. N Engl J Med ,2003,348 (2) : 138-150.
  • 4Matthay MA. Severe sepsis-a new treatment with both anticoagu- lant and antiinflammatory properties[J]. N Engl J Med,2001, 344(10) :759-762.
  • 5Martin DM, Wiiger MT, Prydz H. Tissue Factor and Biotechnology [ J ]. Thrombosis Res, 1998,90 ( 1 ) : 1-25.
  • 6Harlos K, Martin DM, O' Brien DP,et al. Crystal structure of the extracellular region of human tissue factor [ J ]. Nature, 1994, 370(6491 ) :662-666.
  • 7Edgington TS, Mackman N, Brand K,et al. the structural biology of expression and function of tissue factor[ J]. Thromb Haemost, 1991,66( 1 ) :67-79.
  • 8Price GC,Thompson SA,Kam PC. Tissue factor and tissue factor pathway inhibitor[ J]. Anaesthesia,200d ,59(5 ) :483-492.
  • 9李戈,熊石龙,文志斌,贺石林.组织因子与FⅦa的研究进展[J].血栓与止血学,2002,8(4):172-175. 被引量:3
  • 10张园,邱健,洪长江,顾晓龙,冼江,张萍.厄贝沙坦对血管紧张素Ⅱ诱导的人脐静脉内皮细胞产生组织因子的影响[J].医学研究生学报,2007,20(5):463-466. 被引量:5

二级参考文献27

  • 1张园,邱健.组织因子及其非凝血功能的研究进展[J].医学研究生学报,2005,18(7):632-635. 被引量:5
  • 2[1]Giesen PL, Nemerson Y. Tissue factor on the loose. Semin Thromb Hemost, 2000,26: 379-384.
  • 3[2]Henri H, Versteeg HH, Maikel P, et al. The pleiotropic effects of tissue factor: a pcssible role for factor Ⅶ a-induced intracellular signalling? Thromb Haemost, 2001,86: 1353-1359.
  • 4[3]PeppelenboschMP, Versteeg HH. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med, 2001,11 (8): 335-339.
  • 5[4]Yang J, Lee GF, Riederer MA, et al. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor Ⅶa. Thromb Haemost,2002,87(3) 450-458.
  • 6[5]Neuenschwander PF, Vernon JT, Morrissey JH. Tissue factor alters the pK(a) values of catalytically important factor Ⅶ a residues. Biochemistry, 2002,41 (10): 3364-3371.
  • 7[6]Carsten B, Hansen, Charles P, ct al. Tissue factor-mediated endocytosis, recycling, and degradation of factor Ⅶa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor.Blood,2001,97(6): 1712-1720.
  • 8[7]Rao LVM, Ezban M. Active site-blocked activated factor Ⅶ as an effective antithrombotic agent: mechanism of action. Blood Coagul Fibrinolysis,2000,11:135-143.
  • 9[8]Abraham E. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med,2000,28:31-33.
  • 10[9]Camerer E, Gjemes E, Wiiger M, et al. Binding of factor Ⅶa to tissue factor on keratinocytes induces gene expression. J Biol Chem,2000,275: 6580-6585.

共引文献12

同被引文献42

  • 1柳锋,郑智.丹参防治自发性高血压大鼠左室肥厚机制的研究[J].中华急诊医学杂志,2004,13(5):322-324. 被引量:28
  • 2王常田,景华.降钙素原在体外循环炎性反应中的研究[J].医学研究生学报,2004,17(11):1037-1040. 被引量:16
  • 3董春霞,胡豫.内皮细胞表达组织因子的信号转导[J].医学综述,2005,11(5):407-410. 被引量:2
  • 4庄颖,张雅萍.肠源性脓毒症的研究进展[J].国际外科学杂志,2007,34(6):403-406. 被引量:28
  • 5Cadet J. Rapid diagnostic methods in the detection of sepsis[ J ]. Infect Dis Clin North Am,1999,13(2) :483-494.
  • 6Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guideline for the use of innovation therapies in sepsis. The ACCP/SCCM Consensus Committee American College of Chest Physicians/Society of Care Medicine [ J ]. Chest, 1992,101(6) :1644-1655.
  • 7Wanner GA, Keel M, Steckholzer U ,et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients [ J ]. Crit Care Med, 2000,28(4) :950-957.
  • 8Balcli C, Sungnrtekin H, Gurses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [ J ]. Crit Care ,2003,7 ( 1 ) :85-90.
  • 9van Rossum AM,Wulkan RW,Qudesluys-Murphy AM,et al. Procalcitonin as an early marker of infection in neonates and children [Jj. Lancet Infect Dis,2004,4(10) :620-630.
  • 10Roxane C, Stephanie V, Herbert S. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlate[J]. Crit Care Med, 2002, 30 (4) :757-762.

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部